The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Mallinckrodt Plc

NYSE: MNK
Last

(U.S.) $62.35

Today's change+1.83 +3.02%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.
 

Mallinckrodt Plc

NYSE: MNK
Last

(U.S.) $62.35

Today's change+1.83 +3.02%
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Mallinckrodt Plc up sharply

Mallinckrodt Plc closed up sharply Friday, rallying (U.S.)$1.83 or 3.02% to (U.S.)$62.35. Over the last five days, shares have lost 10.26% and are down 16.45% for the last year to date. This security has underperformed the S&P 500 by 33.87% during the last year.

Key company metrics

  • Open(U.S.) $61.44
  • Previous close(U.S.) $60.52
  • High(U.S.) $63.01
  • Low(U.S.) $58.86
  • Bid / Ask-- / --
  • YTD % change-16.45%
  • Volume1,941,486
  • Average volume (10-day)3,063,132
  • Average volume (1-month)2,260,329
  • Average volume (3-month)2,859,535
  • 52-week range(U.S.) $52.01 to (U.S.) $134.26
  • Beta--
  • Trailing P/E21.84×
  • P/E 1 year forward7.75×
  • Forward PEG0.59×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.85
Updated February 12 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.64%

Based on its net profit margin of 9.64%, Mallinckrodt Plc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 25, 201512/25/2015Sep 25, 201509/25/2015Jun 26, 201506/26/2015Mar 27, 201503/27/2015
Revenue915606965910
Total other revenue--------
Total revenue915606965910
Gross profit492393534489
Total cost of revenue423213432421
Total operating expense735500832815
Selling / general / administrative243231333344
Research & development64514547
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)66223
Other operating expenses, total--000
Operating income17910613495
Interest income (expense), net non-operating-98-77-73-57
Gain (loss) on sale of assets--------
Other--------
Income before tax84296142
Income after tax116825877
Income tax, total-32-533-34
Net income211755899
Total adjustments to net income000-1
Net income before extra. items116825877
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items116825776
Inc. avail. to common incl. extra. items211755898
Diluted net income211755898
Dilution adjustment0000
Diluted weighted average shares116118118117
Diluted EPS excluding extraordinary itemsvalue per share1.000.700.480.65
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.030.730.660.66